A new study shows that aspirin can help fight Colon Cancer by over 30%. 

Andrew Chan co-author of The Journal of the American Medical Association said that the studies revealed that patients who took aspirin after diagnosis were 38% less likely to die from any cause during a 12 year trial.  

How it works?

According to Andrew Chan, the type of tumor overproduces a protein called COX-2. When inflammation is involved that is what feeds tumor growth. This new study however, doesn’t benefit patients who didn’t overproduce the protein as well as people who took aspirin before diagnosis. It does benefits patients whose tumors overproduced COX-2 that took aspirin after diagnosis were alive 10 years later as compared to 67% of those patients who didn’t take them. As exciting as this new finding is, always consult with your doctor for advice.

Information provided by USA Today